Showing results (1991-2000 of 4,777) with videos related to

Sort By:
Pageof 478
Brain & Development|July 12, 2025
Valproate and lamotrigine combination therapy in children with drug-resistant focal epilepsy: an observational analysis focusing on neuroimaging abnormalitiesShiena Watanabe, Takashi Enokizono, Mitsuyo Nishimura, et al.
Brain & Development|May 31, 2025
Long-term outcome prediction after pediatric cardiac arrest by continuous electroencephalographyEri Ohashi, Itaru Hayakawa, Hiroki Kato, et al.
Brain & Development|June 20, 2025
Epilepsy phenotypes and responses to antiseizure medications in pediatric patients with EEF1A2-related epilepsyHee-Jeong Yun, Soo Yeon Kim, Woojoong Kim, et al.
Brain & Development|May 27, 2025
Drug-resistant epilepsy in children post-neonatal seizures: Clinical profiles and predictorsWarisara Saenchai, Satit Manopunya, Shanika Kosarat, et al.
Brain & Development|October 17, 2025
Polysomnographic and clinical features of childhood non-REM parasomnias: A sleep center experienceAslı Çıplaklıgil, Duygu Kurt Gök, Hüseyin Per, et al.
Brain & Development|September 28, 2025
Serum matrix metallopeptidase-9 levels in patients with infantile epileptic spasms syndrome before and after the initiation of vigabatrin therapyRyuki Matsuura, Shin-Ichiro Hamano, Atsuro Daida, et al.
Brain & Development|September 26, 2025
Muscle and thyroid manifestations in TANGO2 deficiency disorder: a case study of novel biallelic variantsRyo Sugiyama, Yuko Shimizu-Motohashi, Yuka Sakata, et al.
Brain & Development|September 30, 2025
Impact of the coronavirus disease pandemic on emergency transport times for pediatric febrile seizures: A retrospective studyTaisuke Matsumoto, Masahiro Nishiyama, Yusuke Ishida, et al.
Brain & Development|July 20, 2025
Recognition of Japanese kanji words in children with specific learning disorders: a preliminary study using magnetoencephalographyYuka Egashira, Yoshimi Kaga, Atsuko Gunji, et al.
Brain & Development|July 3, 2025
Early hypoglycemia is not an independent risk factor for 2-year neurodevelopmental impairment in appropriate-for-gestational age preterm infants < 32 weeksMartina Palazzo, Margherita Bonanni, Alessio Correani, et al.
Pageof 478